Dublin, April 09, 2018 -- The "Healthcare/Medical Simulation Market by Product & Services, End User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The medical simulation market is expected to reach USD 2,575.4 million by 2022 from an estimated USD 1,284.0 million in 2017, at a CAGR of 14.9%.
The benefits of simulation over traditional learning, increasing demand for minimally invasive treatments, and increasing focus on patient safety are the major factors driving the growth of the significant growth drivers of the medical simulation market. However, budgetary constraints, high cost of simulators and operational challenges are limiting the adoption of medical simulation up to some extent during the forecast period.
On the basis of product and service, the medical simulation market is segmented into anatomical models, medical simulation software, web-based simulation, and simulation training services. The web-based simulation segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can be attributed to the growing IT infrastructure in educational institutions, widespread availability of internet services, lack of adequate number of educators, rising demand for competency assessment, and controlled access to simulation procedures.
Based on end user, the medical simulation market is segmented into academic institutes, hospitals, military, and other end users. The hospitals segment is expected to grow at the highest CAGR during the forecast period. The advent of advanced simulation-based technologies, wide utilization of simulation models in medical surgeries, increasing focus on minimizing errors, and cost-effectiveness of procedural training for medical physicians, are expected to drive the medical simulation market for hospitals during the forecast period.
North America held the largest share of the global medical simulation market in 2016. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to increasing focus on medical education, training & research, increasing focus on patient safety, and increasing healthcare expenditure.
The prominent players in the global medical simulation market are CAE (Canada), Laerdal Medical (Norway), 3D Systems (US), Simulab Corporation (US), Simulaids (US), Limbs & Things (US), Kyoto Kagaku (Japan), Mentice (Sweden), Medaphor (UK), and Gaumard Scientific Company (US).
Key Topics Covered:
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Limitations
1.5 Currency
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Medical Simulation: Market Overview
4.2 APAC Medical Simulation Market, By Product & Service and Country
4.3 Medical Simulation: Regional Mix
4.4 Healthcare/Medical Simulation Market : Geographical Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Benefits of Simulation Over Traditional Learning
5.2.1.2 Increasing Demand for Minimally Invasive Treatments
5.2.1.3 Increasing Focus on Patient Safety
5.2.2 Restraints
5.2.2.1 Budgetary Constraints
5.2.3 Opportunities
5.2.3.1 Shortage of Healthcare Personnel
5.2.3.2 Technological Advancements
5.2.3.3 Growing Awareness on Simulation Education in Emerging Countries
5.2.4 Challenges
5.2.4.1 High Cost of Simulators
5.2.4.2 Operational Challenges
5.2.4.2.1 Modelling and Simulation of Individual Tissues
5.2.4.2.2 Difficulty in Achieving Multimodal Simulation
5.3 Industry Trends
5.3.1 Virtual Reality and Augmented Reality
5.3.2 Race Towards Top Fidelity
5.3.3 Use of Multidisciplinary Approach in the Development of Simulators
6 Medical Simulation Market, By Product & Service
6.1 Introduction
6.2 Anatomical Models
6.2.1 Patient Simulators
6.2.1.1 High-Fidelity Simulators
6.2.1.2 Medium-Fidelity Simulators
6.2.1.3 Low-Fidelity Simulators
6.2.2 Task Trainers
6.2.3 Interventional/Surgical Simulators
6.2.3.1 Laparoscopic Surgical Simulators
6.2.3.2 Gynecology Surgical Simulators
6.2.3.3 Cardiac Surgical Simulators
6.2.3.4 Arthroscopic Surgical Simulators
6.2.3.5 Other Interventional/Surgical Simulators
6.2.4 Endovascular Simulators
6.2.5 Ultrasound Simulators
6.2.6 Dental Simulators
6.2.7 Eye Simulators
6.3 Web-Based Simulation
6.4 Medical Simulation Software
6.4.1 Performance Recording Software
6.4.2 Virtual Tutors
6.5 Simulation Training Services
6.5.1 Vendor-Based Training
6.5.2 Educational Societies
6.5.3 Custom Consulting & Training Services
7 Medical Simulation Market, By End User
7.1 Introduction
7.2 Academic Institutes
7.3 Hospitals
7.4 Military Organizations
7.5 Other End Users
8 Medical Simulation Market, By Region
9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.2.1 Patient Simulators
9.2.2 Task Trainers
9.2.3 Performance Recording Software
9.3 Competitive Scenario
9.3.1 Product Launches and Enhancements
9.3.2 Partnerships, Agreements, and Collaborations
9.3.3 Acquisitions
9.3.4 Expansions
10 Company Profiles
- 3D Systems
- CAE
- Gaumard Scientific Company
- Kyoto Kagaku
- Laerdal Medical
- Limbs & Things
- Medaphor
- Mentice
- Simulab
- Simulaids
For more information about this report visit https://www.researchandmarkets.com/research/xk9jff/healthcaremedical?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Healthcare Services, Medical Devices, Surgical Devices , Virtual and Augmented Reality


Amazon Explores AI Content Marketplace With Media Publishers
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



